1. Home
  2. GPUS vs REVB Comparison

GPUS vs REVB Comparison

Compare GPUS & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPUS
  • REVB
  • Stock Information
  • Founded
  • GPUS 1969
  • REVB 2020
  • Country
  • GPUS United States
  • REVB United States
  • Employees
  • GPUS N/A
  • REVB N/A
  • Industry
  • GPUS
  • REVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • GPUS
  • REVB Health Care
  • Exchange
  • GPUS NYSE
  • REVB Nasdaq
  • Market Cap
  • GPUS 3.4M
  • REVB 2.8M
  • IPO Year
  • GPUS 1996
  • REVB N/A
  • Fundamental
  • Price
  • GPUS $1.71
  • REVB $2.92
  • Analyst Decision
  • GPUS
  • REVB
  • Analyst Count
  • GPUS 0
  • REVB 0
  • Target Price
  • GPUS N/A
  • REVB N/A
  • AVG Volume (30 Days)
  • GPUS 109.1K
  • REVB 146.9K
  • Earning Date
  • GPUS 05-19-2025
  • REVB 05-09-2025
  • Dividend Yield
  • GPUS N/A
  • REVB N/A
  • EPS Growth
  • GPUS N/A
  • REVB N/A
  • EPS
  • GPUS N/A
  • REVB N/A
  • Revenue
  • GPUS $106,662,000.00
  • REVB N/A
  • Revenue This Year
  • GPUS N/A
  • REVB N/A
  • Revenue Next Year
  • GPUS N/A
  • REVB N/A
  • P/E Ratio
  • GPUS N/A
  • REVB N/A
  • Revenue Growth
  • GPUS N/A
  • REVB N/A
  • 52 Week Low
  • GPUS $1.90
  • REVB $2.36
  • 52 Week High
  • GPUS $20.30
  • REVB $60.80
  • Technical
  • Relative Strength Index (RSI)
  • GPUS N/A
  • REVB 45.77
  • Support Level
  • GPUS N/A
  • REVB $2.76
  • Resistance Level
  • GPUS N/A
  • REVB $3.62
  • Average True Range (ATR)
  • GPUS 0.00
  • REVB 0.41
  • MACD
  • GPUS 0.00
  • REVB 0.02
  • Stochastic Oscillator
  • GPUS 0.00
  • REVB 34.12

About GPUS HYPERSCALE DATA INC

Hyperscale Data Inc, formerly Ault Alliance Inc is a diversified holding company. It operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, crane services, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles. The company has eight reportable segments: Energy and Infrastructure; Technology and Finance; SMC; Sentinum, Inc.; GIGA; TurnOnGreen; ROI; and Ault Disruptive.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

Share on Social Networks: